Nextcure to present at svb securities global biopharma conference

Beltsville, md., feb. 07, 2023 (globe newswire) -- nextcure, inc. (nasdaq: nxtc), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced that it will present at the svb securities global biopharma conference on wednesday, february 15th at 1:40 pm et.
NXTC Ratings Summary
NXTC Quant Ranking